HealthQuill Epilepsy
H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug to treat seizures in a group of rare epilepsies.
Drugs Health Pharma

Lundbeck targets epileptic drug, to buy Longboard for $2.6 billion

H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug.

Read More
Takeda Pharmaceutical Company’s two trials for treating epilepsy did not meet its primary goals of seizure frequency, the Japanese company announced.
Drugs Health Pharma

Takeda’s trials for epilepsy treatment fail to meet primary seizure goals

Takeda Pharmaceutical Company’s two trials for treating epilepsy did not meet its primary goals of seizure frequency, the Japanese company announced.

Read More
Neuroscientists at the University of California, Berkeley, used AI software to reconstruct a song from the brain recordings, adding another brick in the wall of human understanding of processing music. 
Drugs Health Pharma

Berkeley researchers recreate Pink Floyd song from brain activity

HQ Team August 17, 2023: Neuroscientists at the University of California, Berkeley, used AI software to reconstruct a song from the brain recordings,.

Read More
he current treatment of cortical malformations in the anterior parts of the brain, or cerebrum, in vertebrates by its surgical removal to cure epilepsy left scientists with one question. What causes these patches?
Drugs Health Pharma

Decade-long study pinpoints baffling causes of epilepsy in children

he current treatment of cortical malformations in the anterior parts of the brain, or cerebrum, in vertebrates by its surgical removal to cure.

Read More
Epilepsy cannibis
Drugs Pharma

Jazz Pharma says cannabis-based drug aids epilepsy treatment

Jazz Pharmaceuticals Plc announced its plant-derived cannabis epilepsy medicine had improved patients' seizure and non-seizure outcomes.

Read More